Switch to:

Latest Guru Trades with ZMH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Scott Black 2014-06-30 Sold Out 1.3%$90.99 - $107.2 $ 111.2411%0
Robert Olstein 2014-06-30 Add 29.85%0.28%$90.99 - $107.2 $ 111.2411%87000
Andreas Halvorsen 2014-06-30 New Buy0.27%$90.99 - $107.2 $ 111.2411%603193
John Rogers 2014-06-30 Reduce -20.94%0.23%$90.99 - $107.2 $ 111.2411%753063
Joel Greenblatt 2014-06-30 Reduce -89.84%0.06%$90.99 - $107.2 $ 111.2411%4631
Jean-Marie Eveillard 2014-06-30 Reduce -31.25%$90.99 - $107.2 $ 111.2411%1122
Joel Greenblatt 2014-03-31 Add 1594.43%0.06%$90.87 - $98.35 $ 111.2417%45597
Ray Dalio 2014-03-31 Sold Out 0.01%$90.87 - $98.35 $ 111.2417%0
David Dreman 2014-03-31 Add 350.29%0.01%$90.87 - $98.35 $ 111.2417%1531
Private Capital 2013-12-31 Reduce -45.62%1%$82.66 - $93.43 $ 111.2425%158125
John Hussman 2013-12-31 Sold Out 0.25%$82.66 - $93.43 $ 111.2425%0
HOTCHKIS & WILEY 2013-12-31 Reduce -16.69%0.12%$82.66 - $93.43 $ 111.2425%1521304
David Dreman 2013-12-31 Reduce -72.34%0.01%$82.66 - $93.43 $ 111.2425%340
Joel Greenblatt 2013-12-31 Reduce -51.51%0.01%$82.66 - $93.43 $ 111.2425%2691
Ray Dalio 2013-12-31 Reduce -35.26%$82.66 - $93.43 $ 111.2425%6792
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 24.30
ZMH's P/E(ttm) is ranked higher than
87% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 51.70 vs. ZMH: 24.30 )
ZMH' s 10-Year P/E(ttm) Range
Min: 9.08   Max: 61.06
Current: 24.3

9.08
61.06
P/B 2.90
ZMH's P/B is ranked higher than
73% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 3.38 vs. ZMH: 2.90 )
ZMH' s 10-Year P/B Range
Min: 1.31   Max: 6.26
Current: 2.9

1.31
6.26
P/S 4.10
ZMH's P/S is ranked higher than
64% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 3.06 vs. ZMH: 4.10 )
ZMH' s 10-Year P/S Range
Min: 1.82   Max: 8.95
Current: 4.1

1.82
8.95
PFCF 26.50
ZMH's PFCF is ranked higher than
89% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. ZMH: 26.50 )
ZMH' s 10-Year PFCF Range
Min: 9.54   Max: 50.48
Current: 26.5

9.54
50.48
EV-to-EBIT 17.25
ZMH's EV-to-EBIT is ranked higher than
88% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 34.56 vs. ZMH: 17.25 )
ZMH' s 10-Year EV-to-EBIT Range
Min: 6.8   Max: 45.8
Current: 17.25

6.8
45.8
PEG 2.95
ZMH's PEG is ranked higher than
93% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. ZMH: 2.95 )
ZMH' s 10-Year PEG Range
Min: 0.45   Max: 5.43
Current: 2.95

0.45
5.43
Shiller P/E 27.40
ZMH's Shiller P/E is ranked higher than
91% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. ZMH: 27.40 )
ZMH' s 10-Year Shiller P/E Range
Min: 10.71   Max: 39.06
Current: 27.4

10.71
39.06
Current Ratio 4.44
ZMH's Current Ratio is ranked higher than
84% of the 395 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. ZMH: 4.44 )
ZMH' s 10-Year Current Ratio Range
Min: 1.14   Max: 5.09
Current: 4.44

1.14
5.09
Quick Ratio 3.23
ZMH's Quick Ratio is ranked higher than
82% of the 395 Companies
in the Global Medical Devices industry.

( Industry Median: 2.01 vs. ZMH: 3.23 )
ZMH' s 10-Year Quick Ratio Range
Min: 0.71   Max: 3.69
Current: 3.23

0.71
3.69

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.80
ZMH's Dividend Yield is ranked lower than
74% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 1.26 vs. ZMH: 0.80 )
ZMH' s 10-Year Dividend Yield Range
Min: 0.28   Max: 1.1
Current: 0.8

0.28
1.1
Dividend Payout 0.18
ZMH's Dividend Payout is ranked higher than
99% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. ZMH: 0.18 )
ZMH' s 10-Year Dividend Payout Range
Min: 0.15   Max: 0.23
Current: 0.18

0.15
0.23
Yield on cost (5-Year) 0.80
ZMH's Yield on cost (5-Year) is ranked lower than
74% of the 186 Companies
in the Global Medical Devices industry.

( Industry Median: 1.52 vs. ZMH: 0.80 )
ZMH' s 10-Year Yield on cost (5-Year) Range
Min: 0.28   Max: 1.1
Current: 0.8

0.28
1.1
Share Buyback Rate 5.10
ZMH's Share Buyback Rate is ranked higher than
98% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: -0.90 vs. ZMH: 5.10 )
ZMH' s 10-Year Share Buyback Rate Range
Min: 6.6   Max: -8.4
Current: 5.1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 5.90
ZMH's Price/Tangible Book is ranked higher than
70% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 6.00 vs. ZMH: 5.90 )
ZMH' s 10-Year Price/Tangible Book Range
Min: 4.19   Max: 233.33
Current: 5.9

4.19
233.33
Price/DCF (Projected) 1.30
ZMH's Price/DCF (Projected) is ranked higher than
93% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 456.50 vs. ZMH: 1.30 )
ZMH' s 10-Year Price/DCF (Projected) Range
Min: 0.58   Max: 1.74
Current: 1.3

0.58
1.74
Price/Median PS Value 1.20
ZMH's Price/Median PS Value is ranked higher than
73% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 1.13 vs. ZMH: 1.20 )
ZMH' s 10-Year Price/Median PS Value Range
Min: 0.57   Max: 2.64
Current: 1.2

0.57
2.64
Price/Peter Lynch Fair Value 3.30
ZMH's Price/Peter Lynch Fair Value is ranked higher than
93% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. ZMH: 3.30 )
ZMH' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.66   Max: 3.1
Current: 3.3

0.66
3.1
Price/Graham Number 2.50
ZMH's Price/Graham Number is ranked higher than
82% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 7.03 vs. ZMH: 2.50 )
ZMH' s 10-Year Price/Graham Number Range
Min: 1.36   Max: 22.07
Current: 2.5

1.36
22.07
Earnings Yield (Greenblatt) 5.80
ZMH's Earnings Yield (Greenblatt) is ranked higher than
87% of the 391 Companies
in the Global Medical Devices industry.

( Industry Median: 3.50 vs. ZMH: 5.80 )
ZMH' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.2   Max: 14.7
Current: 5.8

2.2
14.7
Forward Rate of Return (Yacktman) 10.48
ZMH's Forward Rate of Return (Yacktman) is ranked higher than
88% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 1.44 vs. ZMH: 10.48 )
ZMH' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 8.9   Max: 43.1
Current: 10.48

8.9
43.1

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, STJ, EW » details
Traded in other countries:ZMH.Switzerland, ZIM.Germany, 0QQD.UK
Zimmer Holdings, Inc., a Delaware corporation was incorporated in 2001. The Company designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products. It also provides other healthcare related services. It has operations in more than 25 countries and market products in more than 100 countries. The Company manages its operations through three major geographic segments - the Americas, which is comprised principally of the United States and includes other North, Central and South American markets; Europe, which is comprised principally of Europe and includes the Middle East and Africa; and Asia Pacific, which is comprised mainly of Japan and Australia and includes other Asian and Pacific markets. It markets and sells products through three principal channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers and directly to dental practices and dental laboratories. The Company's products include orthopaedic reconstructive implants, spinal and trauma devices, biologics, dental implants and related surgical products. Orthopaedic reconstructive implants include Knee Implants, Hip Implants and Extremity implants. Total knee replacement surgeries typically include a femoral component, a patella a tibial tray and an articular surface. Total hip replacement surgeries replace both the head of the femur and the socket portion of the pelvis of the natural hip. Its extremity portfolio, mainly shoulder and elbow products, is designed to treat arthritic conditions, soft tissue injuries and fractures, as well as to enhance the outcome of main or revision surgery. Trauma products include devices used to stabilize damaged or broken bones and their surrounding tissues to support the body's natural healing processes. Spine products division designs, manufactures and distributes medical devices and surgical instruments to deliver comprehensive solutions for those with back or neck pain caused by degenerative conditions, deformities or traumatic injury of the spine. The Company's Biologics group based in Austin, Texas works on biological solutions to repair and regenerate damaged or degenerated musculoskeletal tissues using biomaterials/cell therapies which offer the possibility of treating damaged joints by biological repair rather than replacing them. The Company's dental products division manufactures and distributes: dental reconstructive implants - for individuals who are totally without teeth or are missing one or more teeth; dental restorative products - aimed at providing a more natural restoration to mimic the original teeth and dental regenerative products - for soft tissue and bone rehabilitation. The Company develops, manufactures and markets products that support its reconstructive, trauma, spine and dental implant procedures, with a focus on bone cements, surgical wou
» More Articles for ZMH

Headlines

Articles On GuruFocus.com
Medical Technology Company Offers Investment Opportunity Sep 25 2014 
Simon Properties Reports Insider Trades Mar 13 2013 
Stryker Corporation (SYK) Dividend Stock Analysis Jan 11 2013 
These 5 Stocks Are Most Hated by Big Investors Nov 07 2012 
52-Week High Companies: ZMH, CVX, V, REGN, DFS Sep 10 2012 
5 Healthcare Stocks You Should Know About Mar 31 2012 
5 Healthcare Stocks to Consider for 2012 Mar 27 2012 
Edward Owens’ Vanguard Health Care Fund Biggest Buys in Fourth Quarter Jan 30 2012 
Stocks That Are Cheaper Than When Bill Frels Bought Them Jan 04 2012 
Stryker Corp. (SYK) Dividend Stock Analysis Dec 16 2011 

More From Our Partners
Zimmer Holdings, Inc. (ZMH): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Oct 31 2014 - ZACKS

More From Other Websites
Midday Glance: Medical Devices companies Oct 31 2014
Midday Glance: Medical Devices companies Oct 31 2014
Early Glance: Medical Devices companies Oct 31 2014
Early Glance: Medical Devices companies Oct 31 2014
Final Glance: Medical Devices companies Oct 30 2014
Zimmer will become Zimmer Biomet after acquisition Oct 30 2014
Zimmer will become Zimmer Biomet after acquisition Oct 30 2014
[$$] Zimmer Holdings to Rename Itself Zimmer Biomet Upon Close of Deal Oct 30 2014
ZIMMER HOLDINGS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events,... Oct 30 2014
Oct 30, 2014 Zimmer Announces Executive Leadership Team and New Name of Combined Company Following... Oct 30 2014
8:07 am Zimmer Hldgs announces executive leadership team and new name of combined company following... Oct 30 2014
Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing Oct 30 2014
Final Glance: Medical Devices companies Oct 29 2014
Oct 29, 2014 Zimmer Holdings to Present at 2014 Credit Suisse Healthcare Conference Oct 29 2014
Zimmer Holdings to Present at 2014 Credit Suisse Healthcare Conference Oct 29 2014
Wright Medical, Tornier to Combine in $3.3 Billion Deal Oct 28 2014
BUZZ-Zimmer Holdings Inc: Posts better-than-expected profit Oct 23 2014
Zimmer Beats on Earnings and Revenues Oct 23 2014
[$$] Zimmer's Earnings, Revenue Improve Less Than Expected Oct 23 2014
Oct 23, 2014 Zimmer Holdings, Inc. Reports Third Quarter 2014 Financial Results Oct 23 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK